Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Sibutramine 10mg capsules
0405020S0AAAAAA
|
Sibutramine | Sibutramine | Central Nervous System | No data available |
|
Sibutramine 15mg capsules
0405020S0AAABAB
|
Sibutramine | Sibutramine | Central Nervous System | No data available |
|
Sicura drainable night drainage bag
22602656010
|
Sicura drainable night drainage bag | Night Drainage Bags | Incontinence Appliances | No data available |
|
Sideromal 130mg capsules
0901011H0BDAAAJ
|
Sideromal | Ferrous gluconate | Nutrition and Blood | No data available |
|
Sigma ETB bandage 10cm size F
20090000278
|
Sigma ETB bandage 10cm size F | Stockinette | Dressings | No data available |
|
Sigma ETB bandage 12cm size G
20090000280
|
Sigma ETB bandage 12cm size G | Stockinette | Dressings | No data available |
|
Sigma ETB bandage 6.25cm size B
20090000270
|
Sigma ETB bandage 6.25cm size B | Stockinette | Dressings | No data available |
|
Sigma ETB bandage 6.75cm size C
20090000272
|
Sigma ETB bandage 6.75cm size C | Stockinette | Dressings | No data available |
|
Sigma ETB bandage 7.5cm size D
20090000274
|
Sigma ETB bandage 7.5cm size D | Stockinette | Dressings | No data available |
|
Sigma ETB bandage 8.75cm size E
20090000276
|
Sigma ETB bandage 8.75cm size E | Stockinette | Dressings | No data available |
|
Signifor 0.3mg/1ml solution for injection ampoules
0803043Q0BBAAAA
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.6mg/1ml solution for injection ampoules
0803043Q0BBABAB
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 0.9mg/1ml solution for injection ampoules
0803043Q0BBACAC
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 10mg inj vials
0803043Q0BBAGAG
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 20mg inj vials
0803043Q0BBADAD
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 30mg inj vials
0803043Q0BBAHAH
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 40mg inj vials
0803043Q0BBAEAE
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Signifor 60mg inj vials
0803043Q0BBAFAF
|
Signifor | Pasireotide | Malignant Disease and Immunosuppression | No data available |
|
Sigvaris (12-16mmHg) armsleeve
21270000175
|
Sigvaris (12-16mmHg) armsleeve | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (12-16mmHg) armsleeve with grip top
21270000149
|
Sigvaris (12-16mmHg) armsleeve with grip top | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (12-16mmHg) armsleeve with grip top and hand piece
21270000177
|
Sigvaris (12-16mmHg) armsleeve with grip top and hand piece | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (12-16mmHg) armsleeve with hand piece
21270000176
|
Sigvaris (12-16mmHg) armsleeve with hand piece | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (18-22mmHg) armsleeve
21270000178
|
Sigvaris (18-22mmHg) armsleeve | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (18-22mmHg) armsleeve with grip top
21270000155
|
Sigvaris (18-22mmHg) armsleeve with grip top | Lymphoedema Garments | Appliances | No data available |
|
Sigvaris (18-22mmHg) armsleeve with grip top and hand piece
21270000180
|
Sigvaris (18-22mmHg) armsleeve with grip top and hand piece | Lymphoedema Garments | Appliances | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.